China Health Industries Holdings, Inc. (CHHE)

China Health Industries Holdings, Inc. (CHHE) — VMCI valuation read

CHHE screens at VMCI 43/100, a 7-point gap below the Healthcare sector median (50). For a mid-cap China Health Industries Holdings, Inc. share, that placement says the multi-pillar composite is richer or lower quality than the typical peer on a like-for-like basis.

CHHE has logged no Form 4 insider activity over the trailing 30 days. The tape reads neither bullish nor bearish on insider conviction. The next signal sits with the 10-Q schedule and the analyst calendar.

**Investor frame.** Value: CHHE trades at 22.0x earnings, 22% above the Healthcare median of 18.0x, while EV/EBITDA prints 9.0x against 12.0x for the Healthcare group. Quality: ROIC of 16.0% sits 6.0pp above the Healthcare median (10.0%), the cleanest like-for-like comparison on capital efficiency. Risk: net debt to EBITDA of -0.5x leaves covenant headroom, which sets the rate-cycle exposure for China Health Industries Holdings, Inc..

CHHE rose 1.2% over the trailing 7 days, with a +0.2% read on a 30-day basis.